MedTrace Logo

Performance Study of the SOLO 2.0 Insulin Pump

NCT01500928 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2011-12-29

No results posted yet for this study

Summary

The Purpose of the study is to to evaluate the performance of the SOLO (version 2.0) micropump insulin delivery system, in Type 1 diabetic patients who use insulin pumps for their treatment.

Conditions

Interventions

DEVICE

SOLO insulin pump

Use of the SOLO insulin pump for treatment of type 1 diabetes.

Sponsors & Collaborators

  • Medingo Ltd

    lead INDUSTRY

Principal Investigators

  • Thomas Pieber, MD · Medical University of Graz

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
16 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-07-31
Primary Completion
2012-07-31

Countries

  • Israel

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01500928 on ClinicalTrials.gov